(Date:7/2/2008)...y company to offer choice of two distinct drugs on...orms, NATICK, Mass., July 2 /PRNewswire-FirstCall...oday announced that the U.S. Food and Drug,Adminis...us-Eluting,Coronary Stent System for the treatment... private-labeled XIENCE(TM) V Everolimus-Eluting C...
(Date:7/2/2008)...ming soon to Bioniche,s growing line of injectable...REST, Ill., July 2 /- Bioniche Pharma...le pharmaceuticals, announced today,the acquisitio... line,including:, -- ENLON(R) (edrophonium chl...ON-PLUS(R) (edrophonium chloride, USP and atropine...
(Date:7/2/2008)... Northeastern University Technology Receive Fundin...logy for the Extraction of ...Allied Minds, a pre-seed investment,corporation sp...ures,Harvard University,s Office of Technology De...e creation of CryoXtract Instruments, LLC, a new,s...
(Date:7/2/2008)... potential of pre-treatment R2 levels as a possibl...y -, TORONTO, July 2 / Lor..." or the "Corporation"), a biopharmaceutical compa... pharmaceutical products and,technologies for the ...by,an Ohio State University (OSU) clinical team of...
Breaking Biology Technology:Boston Scientific Announces FDA Approval for PROMUS(TM) Everolimus-Eluting Coronary Stent System 2Boston Scientific Announces FDA Approval for PROMUS(TM) Everolimus-Eluting Coronary Stent System 3Boston Scientific Announces FDA Approval for PROMUS(TM) Everolimus-Eluting Coronary Stent System 4Bioniche Pharma Acquires Baxter's ENLON(R) and ENLON-PLUS(R) 2Investment Firm Allied Minds to Commercialize New Frozen Aliquotter Technology with Two Local Major Universities. 2Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML) 2Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML) 3Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML) 4Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML) 5...Madison, Wis. If the Fusion 2006 CEO-CIO Sympos...esday and Thursday will see the Fluno Center fille... all different places but asking the same questio...o become more like one another than ever before," ... Justice and head of the Wisconsin IT Directors Co...
... Once again, some Wisconsin legislators are pushin...research restrictions that would effectively move...sin,s homegrown researchers at a competitive disad...sary regulation, state lawmakers should await guid...international -- that have recently announced sepa...
... What makes a great place to work? There are many ...eat place to work is one that inspires the passion...al hot buttons are pushed. Workers are turned on b... work in a job or an organization for more than th...aningful than a good salary and generous benefits....
...Pleasant Prairie, Wis. Now that pharmaceutical g...cres of land just across the Wisconsin state line ...hnology observers believe the impending developmen...,s existing biotech companies. , ,While Abbott has...h of its world headquarters in northern Illinois, ...
Other Biology Technology:Fusion 2006 symposium focuses on making IT work for businesses 2Federal and global guidelines on stem cell research offer a level playing field 2Federal and global guidelines on stem cell research offer a level playing field 3What makes a "best place to work"? 2What makes a "best place to work"? 3What makes a "best place to work"? 4What makes a "best place to work"? 5Abbott Labs campus in Kenosha could send ripples through local biotech 2Abbott Labs campus in Kenosha could send ripples through local biotech 3...worms dwelling at deep-sea hydrothermal vents opt ... degrees Fahrenheit) when given a choice of condit...f any animal studied to date. This unique preferen...rms, meal ticket, since they are apparently the on...mats of bacteria that thrive around deep-sea vents...
...measuring blood levels of specialized cells that c...he arterial lining has been discovered by Duke Uni... known as endothelial progenitor cells (EPC), are ... of arterial damage. , The researchers said that t...degree of coronary artery disease or risks for suf...
...anck Institite for Biophysical Chemistry and other...ic resonance spectroscopy (solid-state NMR) with s... potassium channels and toxins combine and change ...develop medications for high blood pressure and ma...ailure (Nature, April 13, 2006). , Our body,s cell...
...sity have taken a "snapshot" of a Velcro-like prot...the dengue virus, a linkup thought to initiate the...spread by mosquitoes, infects more than 50 million...primarily in tropical regions. , During the earli... to the "carbohydrate recognition domain," or CRD,...
Other Biology News:Some like it hot: Worms at deep-sea vents favor a fiery 45-55°C 2Measuring artery repair cells could become new heart disease test 2Measuring artery repair cells could become new heart disease test 3Unraveling the mysteries of poison 2Biologists visualize protein interaction that may initiate viral infection 2Biologists visualize protein interaction that may initiate viral infection 3BD IMag Anti-Mouse CD90.2 (Thy1.2) Particles-MSC 2 x 109 cells
Agarose overlays are commonly used in baculovirus plaque assays. Many commercial "DNA grade" agaroses either contain contaminants that are toxic to insect cells or lack the physical characteristics r
AgarPlaque Plus Agarose 50 grams
Dithiothreitol, 1M from Upstate
Biology Products: